Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and Guidelines-Reference-Cited by-同舟云学术

Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and Guidelines

Published:2020-09-09 Issue:10 Volume:72 Page:e682-e684
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Wright William F¹,Jorgensen Sarah C J²,Spellberg Brad³

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

2. Department of Pharmacy, Mount Sinai Hospital, Toronto, Ontario, Canada

3. Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1360/34047589/ciaa1360.pdf

Reference31 articles.

1. Failure of clinical practice guidelines to meet Institute of Medicine standards: two more decades of little, if any, progress;Kung;Arch Intern Med,2012

2. Vancomycin advanced therapeutic drug monitoring: an exercise in futility or virtuous endeavor to improve drug efficacy and safety?;Dilworth;Clin Infect Dis,2020

3. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists;Rybak;Clin Infect Dis,2009

4. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections;Moise-Broder;Clin Pharmacokinet,2004

5. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists;Rybak;Clin Infect Dis,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is it time to recommend AUC-based vancomycin therapeutic drug monitoring only? A cross-sectional survey in China;Frontiers in Pharmacology;2024-07-12

2. Guidelines for Diagnosis and Management of Infective Endocarditis in Adults;JAMA Network Open;2023-07-31

3. What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value;Microorganisms;2023-02-24

4. Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults;Pharmaceutics;2022-07-13

5. Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults;JAMA Network Open;2022-05-10